Navigation Links
MONOJECT Black Stopper

ProductsMONOJECT Black Stopper
Company Kendall Company
Item MONOJECT Black Stopper
Features 
  • Liquid additive
  • Non-Silicone coated tubes
  • Hematology procedure
  • Westergren sedimentation rate
  • Sterile tube interior
  • Stopper coating - silicone
Description Inquire
Info Kendall Company
Customer Service: (800) 962-9888
Web site: http://www.kendallhq.com

Related medicine products :

1. MONOJECT Blood Collection Needle and Tube Holders
2. MONOJECT CLEAR LABEL Lavender Stopper (for SYSMEX Analyzer)
3. MONOJECT Lavender Stopper (Liquid Additive)
4. MONOJECT Lavender Stopper (Powder Additive)
5. MONOJECT Pink Stopper
6. MONOJECT Blue Stopper
7. MONOJECT Green Stopper
8. MONOJECT Red Stopper (Non-Coated Tube)
9. MONOJECT CLEAR LABEL Red Stopper
10. MONOJECT Red Stopper (Silicone Coated Tube)
11. MONOJECT Royal Blue Stopper (Dry Additive)
Breaking Medicine Technology:RecoverCare Announces the Relocation of Corporate Headquarters to Louisville 2RecoverCare Announces the Relocation of Corporate Headquarters to Louisville 3AMP Receives $1.4 Million Grant From the Bill & Melinda Gates Foundation to Improve Advocacy for VACCINES and Immunization Systems in West Africa 2AMP Receives $1.4 Million Grant From the Bill & Melinda Gates Foundation to Improve Advocacy for VACCINES and Immunization Systems in West Africa 3Novartis Tasigna(R) (nilotinib) Trial Shows Superior Results to Glivec(R) (imatinib) in Newly Diagnosed, Chronic Phase Chronic Myeloid Leukaemia 2Novartis Tasigna(R) (nilotinib) Trial Shows Superior Results to Glivec(R) (imatinib) in Newly Diagnosed, Chronic Phase Chronic Myeloid Leukaemia 3Novartis Tasigna(R) (nilotinib) Trial Shows Superior Results to Glivec(R) (imatinib) in Newly Diagnosed, Chronic Phase Chronic Myeloid Leukaemia 4Novartis Tasigna(R) (nilotinib) Trial Shows Superior Results to Glivec(R) (imatinib) in Newly Diagnosed, Chronic Phase Chronic Myeloid Leukaemia 5Novartis Tasigna(R) (nilotinib) Trial Shows Superior Results to Glivec(R) (imatinib) in Newly Diagnosed, Chronic Phase Chronic Myeloid Leukaemia 6Skincare Industry Newcomer Shines 51058 1Skincare Industry Newcomer Shines 51058 2For Treatment of Dyslipidemia Surveyed Physicians are Increasingly Switching Patients to a More Potent Statin Following the ENHANCE and SEAS Trials 51055 1For Treatment of Dyslipidemia Surveyed Physicians are Increasingly Switching Patients to a More Potent Statin Following the ENHANCE and SEAS Trials 51055 2For Treatment of Dyslipidemia Surveyed Physicians are Increasingly Switching Patients to a More Potent Statin Following the ENHANCE and SEAS Trials 51055 3Allied World Schedules Second Quarter 2009 Earnings Announcement and Conference Call 51052 1